Protocol Ledger

NCT03970447 · Phase II/III · RECRUITING

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Interventional Phase II/III clinical trial protocol NCT03970447 sponsored by Global Coalition for Adaptive Research in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-07-30 Enrollment: 2,250 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03970447
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)2,250 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03970447
Protocol FieldVerified Registry Value
NCT IdentifierNCT03970447
Consolidated Lead SponsorGlobal Coalition for Adaptive Research
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment2,250 participants (ESTIMATED)
Registered Start Date2019-07-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI